Medical Doctor Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Matthew Cascio

Pain Medicine Jacksonville, FL Medical Doctor

NPI 1952921447 CMS profile 11648205

4500 San Pablo Rd S, Ste 104, Jacksonville, FL 32224

Open in the dashboard

General payments

$5,036

24 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Cascio of Jacksonville, FL is reported in the CMS Open Payments database as having received $5,036 across 24 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $920 22
2024 General $4,116 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Cascio
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Matthew Cascio were reported at $920. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Matthew Cascio Pain Medicine median Middle half National median
2019 $0 $506 $144–$1,566 $163
2020 $0 $315 $96–$934 $114
2021 $0 $452 $134–$1,237 $132
2022 $0 $475 $124–$1,407 $149
2023 $0 $480 $136–$1,384 $160
2024 $4,116 $521 $164–$1,511 $164
2025 $920 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Medtronic, Inc. $4,395 10 payments
  2. SPR Therapeutics, Inc $286 4 payments
  3. Nalu Medical, Inc. $137 1 payment
  4. AbbVie, Inc. $67 3 payments
  5. Vertex Pharmaceuticals Incorporated $57 2 payments
  6. BIOTRONIK NRO, Inc. $27 1 payment
  7. Boston Scientific Corporation $26 1 payment
  8. Collegium Pharmaceutical, Inc. $24 1 payment
  9. Stryker Corporation $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Grant $4,000 1 payment
  2. Food and Beverage $1,036 23 payments
Products named General payments · program years 2024–2025
  1. SYNCHROMEDII $4,043 2 payments
  2. SPRINT PNS System $286 4 payments
  3. INCEPTIV $253 6 payments
  4. Nalu Neurostimulation System $137 1 payment
  5. INTELLIS ADAPTIVESTIM $94 1 payment
  6. QULIPTA $67 3 payments
  7. BOTOX $67 3 payments
  8. JOURNAVX $57 2 payments
  9. Prospera $27 1 payment
  10. Intracept $26 1 payment
  11. Other $46 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$3,793

Medicare's payments for the services billed

Medicare patients

27

Average age 73

Services billed

32

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

24 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record